SCHEMBL30646030

SCHEMBL30646030

COc1cc2c(Oc3ccc([N+](=O)[O-])cc3)ncnc2cc1OC1CCN(C(C)=O)CC1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 2/20 0.51
▸ BACE1 P56817 2/20 0.51
▸ PIK3CD O00329 2/20 0.50
▸ PIK3CA P42336 2/20 0.50
▸ PIK3CB P42338 2/20 0.50
▸ PIK3CG P48736 2/20 0.50
▸ PDGFRA P16234 5/20 0.49
▸ KIT P10721 2/20 0.49
▸ PDGFRB P09619 2/20 0.49
▸ FLT3 P36888 1/20 0.49
▸ KDR P35968 8/20 0.48
▸ EGFR P00533 1/20 0.47
▸ ERBB2 P04626 1/20 0.47
▸ CSF1R P07333 1/20 0.47
▸ ABCG2 Q9UNQ0 1/20 0.45
▸ BRAF P15056 1/20 0.45
▸ MAPK7 Q13164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29111054 1.00 ACHE (0.51) ACHEBACE1PIK3CDPIK3CAPIK3CB
SCHEMBL29111048 0.90 BRAF (0.55) ACHEBACE1PIK3CDPIK3CAPIK3CB
SCHEMBL29111053 0.87 PDGFRA (0.62) PDGFRAKITPDGFRBKDR
SCHEMBL30646019 0.87 PDGFRA (0.62) PDGFRAKITPDGFRBKDR
SCHEMBL28421305 0.86 PIK3CD (0.54) ACHEBACE1PIK3CDPIK3CAPIK3CB
SCHEMBL29111051 0.85 ACHE (0.50) ACHEBACE1PDGFRAKITPDGFRB
SCHEMBL30646045 0.85 ACHE (0.50) ACHEBACE1PDGFRAKITPDGFRB
SCHEMBL28433303 0.83 KDR (0.53) PIK3CDPIK3CAPIK3CBPIK3CGPDGFRA
SCHEMBL30646043 0.83 KDR (0.53) PIK3CDPIK3CAPIK3CBPIK3CGPDGFRA
SCHEMBL28425382 0.79 PDGFRA (0.44) ACHEBACE1PDGFRAKITPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111253385-B Heterocyclic compound, preparation method and application 遵义医科大学珠海校区 2023-11-24 — — CN disclosed
Send feedback